| Literature DB >> 35001016 |
Sebastiaan H Hulstein1, Hanne M L Zimmermann1, Feline de la Court1, Amy A Matser, Maarten F Schim van der Loeff, Elske Hoornenborg1, Udi Davidovich1, Maria Prins, Henry J C de Vries.
Abstract
BACKGROUND: The uptake of preexposure prophylaxis (PrEP) against HIV is low among young men who have sex with men (MSM) in the Netherlands. Studying the intention to use PrEP among non-PrEP using young and older MSM can guide health authorities in developing new prevention campaigns to optimize PrEP uptake.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35001016 PMCID: PMC8994038 DOI: 10.1097/OLQ.0000000000001599
Source DB: PubMed Journal: Sex Transm Dis ISSN: 0148-5717 Impact factor: 3.868
An Overview of the Statements and Questions Used to Assess the Different Psychosocial Determinants of PrEP Intention Among YMSM Who Participated in an Online Survey Between March 2019 and March 2020 and Older MSM Who Participated in a Prospective Cohort Study Between January and June 2019 in the Netherlands
| Psychosocial Determinants of PrEP Intention | YMSM | Older MSM |
|---|---|---|
| Intention to use PrEP | ||
| Intention to use PrEP | ||
| Question/statement | Are you planning to use PrEP in the coming 6 mo? | Are you planning to use PrEP in the coming 6 mo? |
| Response (Likert-like scale) | Very unlikely–very likely[ | Very unlikely–very likely[ |
| Knowledge | ||
| HIV resistance | Not assessed among older MSM | |
| Question/statement | When you take PrEP while unknowingly having HIV, this can make HIV harder to treat (HIV resistance develops) | |
| Response | True/False/I do not know | |
| HIV is an STI | ||
| Question/statement | HIV is a sexually transmitted infection (STI) | |
| Response | True/False/I do not know | |
| HIV can be deadly | ||
| Question/statement | HIV is deadly if left untreated | |
| Response | True/False/I do not know | |
| HIV transmission | ||
| Question/statement | The chance of contracting HIV is larger when fucking than when giving a blowjob | |
| Response | True/False//I do not know | |
| PrEP offers nearly perfect protection against HIV | ||
| Question/statement | PrEP protects really well against HIV | |
| Response | True/False/I do not know | |
| PrEP protects against HIV only | ||
| Question/statement | PrEP not only protects against HIV, it also protects against other STIs (chlamydia, gonorrhea, syphilis) | |
| Response | True/False/I do not know | |
| PrEP dosing regimen | ||
| Question/statement | PrEP can be taken daily or event-driven (around sex) | |
| Response | True/False/I do not know | |
| Risk perception | ||
| HIV risk perception | ||
| Question/statement | How much risk you think you would have contracting HIV in the coming month? | How much risk you think you would have contracting HIV in the coming 6 mo? |
| Response (Likert-like scale) | A very low risk–a very high risk[ | A very low risk–a very high risk[ |
| Anticipation of regret of infected with HIV | ||
| Question/statement | How bad would you feel if you would contract HIV in the coming month? | How bad would you feel if you would contract HIV in the coming 6 mo? |
| Response (Likert-like scale) | Not at all bad–very bad[ | Not bad at all–very bad[ |
| Attitude toward PrEP | ||
| PrEP as prevention tool | ||
| Question/statement | I think PrEP use to prevent HIV is | To use PrEP to protect myself against HIV in the coming 6 mo is I think |
| Response (Likert-like scale) | Very unimportant–very important[ | Very unimportant–very important[ |
| PrEP use for condomless sex | ||
| Question/statement | I think using PrEP to have sex without a condom is | I think using PrEP to have sex without a condom in the coming 6 mo is |
| Response (Likert-like scale) | Very bad–very good[ | Very bad–very good[ |
| Beliefs and expectations | ||
| PrEP offers protection against HIV | ||
| Question/statement | If I use PrEP, I am protected against an HIV infection | The use of PrEP is effective enough to prevent HIV for myself |
| Response (Likert-like scale) | Strongly agree–strongly disagree[ | Strongly agree–strongly disagree[ |
| PrEP use increases sexual pleasure | ||
| Question/statement | If I use PrEP, my pleasure in sex will increase | The use of PrEP increases the quality of my sex life |
| Response (Likert-like scale) | Strongly agree–strongly disagree[ | Strongly agree–strongly disagree[ |
| PrEP use leads to side-effects | ||
| Question/statement | If I use PrEP, I will probably get unpleasant short-term side effects | The use of PrEP leads to many side-effects |
| Response (Likert-like scale) | Strongly agree–strongly disagree[ | Strongly agree–strongly disagree[ |
| PrEP is easier to use than condoms | ||
| Question/statement | PrEP is easier to use than condoms in preventing HIV | The use of PrEP is more difficult to use than condoms |
| Response (Likert-like scale) | Strongly agree–strongly disagree[ | Strongly agree–strongly disagree[ |
| Social norms | In general, other gay men perceive PrEP users as… | |
| PrEP users have a better sex life than nonusers | ||
| Question/statement | I think PrEP users have a more enjoyable sex life | …someone with a more enjoyable sex life |
| Response (Likert-like scale) | Strongly agree–strongly disagree[ | Strongly agree–strongly disagree[ |
| PrEP users take more sexual risk | ||
| Question/statement | I think PrEP users take more sexual risk | …someone who takes more sexual risk |
| Response (Likert-like scale) | Strongly agree–strongly disagree[ | Strongly agree–strongly disagree[ |
| PrEP users take care of their own and others' health | ||
| Question/statement | I think PrEP users take care of their own health and that of their sex partner(s) | …someone who takes care of their own health and that of their sex partner(s) |
| Response (Likert-like scale) | Strongly agree–strongly disagree[ | Strongly agree–strongly disagree[ |
| Self-efficacy | ||
| Acquisition of sufficient PrEP | Do you think you are able to… | |
| Question/statement | Do you think you are able to get a prescription for enough PrEP for your desired use? | …get a prescription for enough PrEP for your desired daily use? |
| Response (Likert-like scale) | Not at all able–very able[ | Not at all able–very able[ |
| Taking PrEP correctly | ||
| Question/statement | Do you think you are able to take PrEP properly for an optimal HIV protection? | …to correctly use daily PrEP? |
| Response (Likert-like scale) | Not at all able–very able[ | Not at all able–very able[ |
| Willingness to pay for PrEP | Not assessed among older MSM | |
| Willingness to pay €1.00 for PrEP | ||
| Question/statement | Would you be willing to pay €1.00 per PrEP tablet? | |
| Response (Likert-like scale) | Not at all willing–absolutely willing[ | |
| Willingness to pay €0.50 for PrEP | ||
| Question/statement | Would you be willing to pay €0.50 per PrEP tablet? | |
| Response (Likert-like scale) | Not at all willing–absolutely wiling[ |
Figure 1Flowchart of selection procedure of YMSM and older MSM. A, 138 YMSM did not complete the questionnaire after starting it. B, MSM who did not meet the inclusion criteria were not allowed to complete the questionnaire beyond the first page, and consequently, no data were saved. MSM, men who have sex with men; YMSM, young MSM.
Sociodemographics, Behavior, and Psychosocial Determinants of PrEP Use Intention of HIV-Negative Young Men Who Have Sex With Men (YMSM; Aged ≤25 Years; n = 93) Participating in an Online Survey Between March 2019 and March 2020, and Older HIV-Negative MSM (Aged ≥26 Years; n = 290) Who Participated in a Prospective Cohort Study Between January and June 2019 in the Netherlands
| YMSM (n = 93) | Older MSM (n = 290) | |||
|---|---|---|---|---|
| Variables | n | % | n | % |
| Age, y | ||||
| 16–18 | 4 | 4.3 | N/A | |
| 19–22 | 31 | 33.3 | N/A | |
| 23–25 | 58 | 62.4 | N/A | |
| 26–34 | N/A | 77 | 26.6 | |
| 35–44 | N/A | 86 | 29.7 | |
| 45–54 | N/A | 90 | 31.0 | |
| 55+ | N/A | 37 | 12.8 | |
| Sex | ||||
| Male | 93 | 100 | 290 | 100 |
| Other | 1 | 1.1 | 0 | 0 |
| Education* | ||||
| Low | 5 | 5.4 | 3/285 | 1.1 |
| Middle | 19 | 20.4 | 48/285 | 16.8 |
| High | 69 | 74.2 | 235/285 | 82.1 |
| Median number of anal sex partners in the past 3 mo† (IQR) | 3 | (2–6) | 1 | (1–3) |
| Condomless anal sex in the past 3 mo | 66 | 71.0 | 219 | 75.3 |
| No | 27 | 29.0 | 71 | 24.5 |
| Yes | 66 | 71.0 | 219 | 75.5 |
| Median number of condomless anal sex partners in the past 3 mo†‡ (IQR) | 2 | (1–3) | 1 | (1-1) |
| Chemsex in the past 6 mo | ||||
| No | 68 | 73.1 | 257 | 88.6 |
| Yes | 25 | 26.9 | 33 | 11.4 |
| GHB use if participant engaged in chemsex in the past 6 mo | ||||
| No | 0/25 | 0 | 2/33 | 6.1 |
| Yes | 25/25 | 100 | 31/33 | 93.9 |
| Mephedrone use if participant engaged in chemsex in the past 6 mo | ||||
| No | 19/25 | 76.0 | 29/33 | 87.9 |
| Yes | 6/25 | 24.0 | 4/33 | 12.1 |
| Methamphetamine use if participants engaged in chemsex in the past 6 mo | ||||
| No | 20/25 | 80.0 | 30/33 | 90.9 |
| Yes | 5/25 | 20.0 | 3/33 | 9.1 |
| PrEP eligibility§ | ||||
| No | 23 | 24.7 | 65 | 22.4 |
| Yes | 70 | 75.3 | 225 | 77.6 |
| Intention to use PrEP | ||||
| 1 (very unlikely) | 13 | 14.0 | 77 | 26.6 |
| 2 | 13 | 14.0 | 67 | 23.1 |
| 3 | 21 | 22.6 | 23 | 7.9 |
| 4 | 17 | 18.3 | 36 | 12.4 |
| 5 (max for YMSM) | 29 | 31.2 | 45 | 15.5 |
| 6 | N/A | 22 | 7.6 | |
| 7 (very likely) | N/A | 20 | 6.9 | |
| Intention to use PrEP (binary) | ||||
| Low intention to us PrEP | 47 | 50.5 | 203 | 70.0 |
| High Intention to use PrEP | 46 | 49.5 | 87 | 30.0 |
| Median scores on psychosocial determinants of PrEP use intention (IQR)¶∥ | ||||
| Median willingness to pay €1.00 per tablet for PrEP | 4 | (3–5) | N/A | |
| Median willingness to pay €0.50 per tablet for PrEP | 5 | (4–5) | N/A | |
| Sum of PrEP knowledge (only YMSM), median score | 6 | (5–6) | N/A | |
| HIV risk | 2 | (1–2) | 2 | (2–3) |
| Anticipation of regret if infected with HIV | 5 | (4–5) | 7 | (7–7) |
| Importance of PrEP as HIV prevention tool | 4 | (4–5) | 4 | (3–6) |
| Positive attitude toward PrEP for condomless sex | 3 | (2–3) | 4 | (2–5) |
| Belief PrEP offers protection against HIV | 4 | (4–5) | 5 | (4–6) |
| Belief PrEP increases sexual pleasure** | 3 | (2–4) | 5 | (4–6) |
| Belief PrEP leads to side effects | 3 | (2–3) | 4 | (3–5) |
| Belief PrEP is easier to use than condoms to prevent HIV | 3 | (2–4) | 5 | (4–6) |
| Social belief PrEP users have a better sex life | 3 | (3–4) | 4 | (3–5) |
| Social belief PrEP users take more sexual risk | 4 | (3–4) | 5 | (4–6) |
| Social belief PrEP users take care of their own or other's health | 4 | (3–4) | 5 | (4–6) |
| Self-efficacy to acquire sufficient PrEP for their needs | 4 | (3–5) | 5 | (4–6) |
| Self-efficacy to adhere to PrEP correctly | 5 | (4–5) | 6 | (5–7) |
*Totals may not add up in columns because of missings.
†Self-reported number of anal sex partners in the past 3 months. The number of anal sex partners has been halved for older MSM to correct for the difference in recall period (3 vs. 6 months).
‡Among participants who reported to have engaged in condomless anal sex in the past 3 months.
§Based on self-reported condomless anal sex, PEP, or anal STI or syphilis in the past 6 months.
¶For YMSM, the scale measuring agreement to the psychosocial determinants ranged from 1 to 5; and for older MSM, from 1 to 7.
∥For presentation purposes, we present the median of the scores on the Likert scales of the respective variable.
**Sexual pleasure has been measured using the following statements: “If I use PrEP, my pleasure in sex will increase” among YMSM and “The use of PrEP increases the quality of my sex life” among older MSM.
ACS, Amsterdam Cohort Studies; GHB, γ-hydroxybutyric acid; HIV, human immunodeficiency virus; IQR, interquartile range; MSM, men who have sex with men; N, number; N/A, not applicable; PEP, postexposure prophylaxis against HIV; %, percentage; PrEP, preexposure prophylaxis against HIV; STI, sexually transmitted infection; YMSM, young MSM.
Logistic Regression Analyses of the Association of Sociodemographic, Behavioral, and Psychosocial Factors With a High PrEP Use Intention Among YMSM Who Participated in an Online Survey Between March 2019 and March 2020 and Older MSM Who Participated in the Prospective Amsterdam Cohort Study Between January and June 2019
| YMSM (n = 93) | Older MSM (n = 290) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n/N* | % | OR | 95% CI | aOR | 95% CI | n/N† | % | OR | 95% CI | aOR | (95% CI) | ||||
| Age, y∥ | |||||||||||||||
| 16–22 | 15/35 | 42.9 | 1 | - | - | ||||||||||
| 23–25 | 31/58 | 53.5 | 0.66–3.56 | 1.56 | 0.59–4.15 | - | - | ||||||||
| 26–44 | - | - | 48/163 | 29.5 | 1 | 1 | |||||||||
| 45+ | - | - | 39/127 | 30.7 | 1.06 | 0.64–1.76 | 1.55 | 0.77–3.14 | |||||||
| Sex | |||||||||||||||
| Male | 45/92 | 48.9 | N/A | 87/290 | 30.0 | N/A | |||||||||
| Other | 1/1 | 100 | 0 | 0 | |||||||||||
| Education | |||||||||||||||
| Low/middle | 14/24 | 58.3 | 1 | 15/51 | 29.4 | 1 | |||||||||
| High | 32/69 | 46.4 | 0.62 | (0.24–1.58) | 70/234 | 29.9 | 1.02 | (0.53–1.99) | |||||||
| No. anal sex partners** | |||||||||||||||
| 1 anal sex partner | 7/19 | 36.8 | 1 | 32/166 | 19.3 | 1 | 1 | ||||||||
| 2 anal sex partners | 9/19 | 47.4 | 1.54 | 0.42–5.64 | 21/48 | 43.8 | 3.26†† | 1.64–6.48 | 3.32 | 1.31–8.42 | |||||
| 3–4 anal sex partners | 7/23 | 30.4 | 0.75 | 0.21–2.72 | 16/41 | 39.0 | 2.68†† | 1.28–5.60 | 4.01 | 1.45–11.07 | |||||
| 5 or more anal sex partners | 23/32 | 71.9 | 4.38†† | 1.31–14.68 | 18/35 | 51.4 | 4.43†† | 2.06–9.54 | 3.70 | 1.39–9.86 | |||||
| Having engaged in condomless anal sex in the past 3 mo | |||||||||||||||
| No | 11/27 | 40.7 | 1 | 20/71 | 28.2 | 1 | |||||||||
| Yes | 35/63 | 53.0 | 1.64 | 0.66–4.07 | 67/219 | 30.6 | 1.12 | 0.62–2.03 | |||||||
| No. condomless anal sex partners**†† | |||||||||||||||
| No condomless anal sex partners | 11/27 | 40.7 | 1 | 25/90 | 27.8 | 1 | |||||||||
| 1 condomless anal sex partner | 12/24 | 50.0 | 1.45 | 0.48–4.41 | 42/160 | 26.3 | 0.93 | 0.52–1.65 | |||||||
| 2 condomless anal sex partners | 6/15 | 40.0 | 0.97 | 0.27–3.51 | 9/22 | 40.9 | 1.80 | 0.68–4.73 | |||||||
| 3 or more condomless anal sex partners | 17/27 | 63.0 | 2.47§ | 0.83–7.39 | 11/18 | 61.1 | 4.09§ | 1.42–11.24 | |||||||
| Chemsex in the past 6 mo | |||||||||||||||
| No | 30/68 | 44.1 | 1 | 67/257 | 26.1 | 1 | 1 | ||||||||
| Yes | 16/25 | 64.0 | 2.25§ | 0.87–5.80 | 20/33 | 60.6 | 4.36¶ | 2.06–9.25 | 3.33 | 1.18–9.35 | |||||
| PrEP eligibility‡‡ | |||||||||||||||
| No | 10/23 | 43.5 | 1 | 18/65 | 27.7 | 1 | |||||||||
| Yes | 36/70 | 51.4 | 1.38 | 0.53–3.55 | 69/225 | 30.7 | 1.15 | 0.63–2.13 | |||||||
| PrEP knowledge | |||||||||||||||
| Low/moderate PrEP knowledge | 5/17 | 29.4 | 1 | 1 | N/A | ||||||||||
| High PrEP knowledge | 41/76 | 54.0 | 2.81 | 0.9–8.76§ | 4.10 | 1.53–11.01 | N/A | ||||||||
| Willingness to pay for PrEP | |||||||||||||||
| Low willingness to pay €1.00 per tablet for PrEP | 15/40 | 37.5 | 1 | N/A | |||||||||||
| High willingness to pay €1.00 per tablet for PrEP | 31/53 | 58.5 | 2.35¶ | 1.01–5.45 | N/A | ||||||||||
| Low willingness to pay €0.50 per tablet for PrEP | 3/14 | 21.4 | 1 | N/A | |||||||||||
| High willingness to pay €0.50 per tablet for PrEP | 43/79 | 54.4 | 4.38¶ | 1.13–16.91 | N/A | ||||||||||
| A strong perception of§§ | |||||||||||||||
| HIV risk | 12/20 | 60.0 | 1.72 | 0.63–4.70 | 16/29 | 55.2 | 3.29¶ | 1.51–7.19 | 4.23 | 1.40–12.76 | |||||
| Anticipation of regret if infected with HIV | 38/80 | 47.5 | 0.57 | 0.17–1.88 | 85/278 | 30.6 | 2.20§ | 0.47–10.27 | |||||||
| Importance of PrEP as HIV prevention tool | 43/73 | 58.9 | 8.12¶ | 2.19–30.19 | 7.61 | 1.84–31.41 | 81/144 | 56.3 | 30.0¶ | 12.43–72.39 | 23.19 | 8.80–61.09 | |||
| Positive attitude toward PrEP for condomless sex | 13/21 | 61.9 | 1.92 | 0.71–5.20 | 61/111 | 55.0 | 7.18¶ | 4.10–12.56 | |||||||
| Belief PrEP offers protection against HIV | 40/77 | 52.0 | 1.80 | 0.60–5.45 | 70/201 | 34.8 | 2.26¶ | 1.24–4.14 | |||||||
| Belief PrEP increases sexual pleasure¶¶ | 27/44 | 61.4 | 2.51¶ | 1.09–5.78 | 70/161 | 43.5 | 5.07¶ | 2.79–9.21 | 2.76 | 1.25–6.08 | |||||
| Belief PrEP leads to side-effects | 9/16 | 56.3 | 1.39 | 0.47–4.11 | 16/73 | 21.9 | 0.58§ | 0.31–1.08 | 0.34 | 0.15–0.78 | |||||
| Belief PrEP is easier than condom use to prevent HIV | 19/36 | 52.8 | 1.24 | 0.54–2.86 | 59/167 | 35.3 | 1.85¶ | 1.09–3.14 | |||||||
| Social belief PrEP users have a better sex life | 23/40 | 57.5 | 1.76 | 0.77–4.04 | 40/108 | 37.0 | 1.69§ | 1.01–2.82 | |||||||
| Social belief PrEP users take more sexual risk | 25/64 | 39.1 | 0.24¶ | 0.09–0.64 | 52/183 | 28.4 | 0.82 | 0.49–1.37 | |||||||
| Social belief PrEP users take care of their own or other's health | 30/47 | 63.8 | 3.31¶ | 1.41–7.74 | 3.34 | 1.26–8.85 | 68/203 | 33.5 | 1.80¶ | 1.00–3.24 | |||||
| Self-efficacy to acquire sufficient PrEP for their needs | 36/62 | 58.1 | 2.91¶ | 1.17–7.20 | 38/128 | 29.7 | 0.97 | 0.58–1.63 | |||||||
| Self-efficacy to adhere to PrEP correctly | 43/78 | 55.1 | 4.91¶ | 1.28–18.80 | 46/158 | 29.1 | 0.91 | 0.54–1.52 | |||||||
*Proportion of YMSM with high PrEP use intention of all YMSM with the variable of interest.
†Proportion of older MSM with high PrEP intention of all older MSM with the variable of interest.
‡We assessed the responses to a question on PrEP use intention, to define high PrEP use intention. For YMSM, high PrEP use intention was defined as the response to the question of 4 to 5 on a Likert-like scale; for older MSM, a response of 5 to 7 was defined as high PrEP use intention.
§Overall: 0.05 ≥ P < 0.10 in univariable analysis.
¶Overall P < 0.05 in univariable analysis.
∥The variable was included as a confounder in the multivariable logistic regression analyses.
**Self-reported number of anal sex partners in the past 3 months. The number of anal sex partners has been halved for older MSM to correct for the difference in recall period (3 vs. 6 months).
††Among participants who reported to have engaged in condomless anal sex in the past 3 months.
‡‡Based on self-reported condomless anal sex, PEP, or anal STI or syphilis in the past 6 months.
§§For YMSM, the scale measuring agreement to the psychosocial determinants ranged from 1 to 5; and for older MSM, from 1 to 7. Scores of 3 to 5 were grouped as high agreement to the determinant among YMSM, and scores 4 to 7 as high among older MSM.
¶¶Sexual pleasure has been measured using the following statements: “If I use PrEP, my pleasure in sex will increase” among YMSM and “The use of PrEP increases the quality of my sex life” among older MSM.
aOR, adjusted odds ratio; CI, confidence ratio; HIV, human immunodeficiency virus; IQR, interquartile range; MSM, men who have sex with men; n, number; N/A, not applicable; OR, odds ratio; %, row percentage; PrEP, preexposure prophylaxis against HIV; YMSM, young MSM.